… programs towards the clinic in our effort to bring more innovative medicines for inherited retinal diseases to … abstract was presented at the Retinal Cell & Gene Therapy Innovation Summit, three abstracts were presented at the …
Post-hoc analyses from Illuminate trial of sepofarsen demonstrate an encouraging efficacy signal when comparing active treatment and sham eyes to their corresponding contralateral eyes across multiple endpoints – Company plans to discuss findings with regulators and pr